Endoscopic surveillance of Barrett's esophagus: A cost-effectiveness comparison with mammographic surveillance for breast cancer

American Journal of Gastroenterology

Volumn 93, Issue 6, 1998, Pages 911-915

  Streitz Jr , John M ^a   Ellis Jr , F Henry ^b   Tilden, Robert L ^b   Erickson, Robert V ^b  

^a Duluth Clinic   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; BREAST CARCINOMA; CANCER EPIDEMIOLOGY; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DIGESTIVE TRACT ENDOSCOPY; EARLY DIAGNOSIS; ESOPHAGUS CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OCCULT CANCER; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; HUMANS; LIFE EXPECTANCY; MAMMOGRAPHY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 0032105372     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(98)00156-7     Document Type: Article

References (29)

1. 1. Streitz JM Jr, Andrews CW Jr, Ellis FH Jr. Endoscopic surveillance of Barrett's esophagus: Does it help? J Thor Cardiovasc Surg 1993;105: 383-8.
2. 2. Altorki NK, Sunagawa M, Little AG, et al. High-grade dysplasia in the columnar-lined esophagus. Am J Surg 1991;161:97-100.
3. 3. Pera M, Tastek VF, Carpenter HA, et al. Barrett's esophagus with high-grade dysplasia: An indication for esophagectomy? Ann Thorac Surg 1992;54:199-204.
4. 4. Kerlikowske K, Grady D, Ruben SM, et al. Efficacy of screening mammography; a meta analysis. JAMA 1995;273:149-54.
5. 5. National Cancer Institute's "Statistics, epidemiology and end results" data, 1995 ed.
6. 6. Statistical Abstract of the United States, 1995 ed., p. 86.
7. 7. Ohuchi N, Yoshida K, Kimura M, et al. Improved detection rate of early breast cancer in mass screening combined with mammography. Jpn J Cancer Res 1993;84:807-12.
8. 8. Paci L, Perfetti P, Zappa M, et al. First results of a mammographic screening program in two municipalities of Massa-Carrara Province. Tumori 1993;79:26-9.
9. 9. Burhenne LJ, Hislop TG, Burhenne HJ. The British Columbia Mammography Screening Program: Evaluation of the first 15 months. AJR 1992;158:45-9.
10. 10. Menon A, Devlin NJ, Richardson AK. The costs of mammography screening in New Zealand: Evidence from the pilot programmes. N Z J 1994;107:501-3.
11. 11. Daures JP, Peray P, Bousquet J, et al. Mass screening for breast cancer in Herault county. First results in women between 40 and 70 years old. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 1992;21:173-8.
12. 12. Chamberlain J, Moss SM, Kirkpatrick AE, et al. National Health Service breast screening programme results for 1991-2. Br Med J 1993;307:353-6.
13. 13. Faulk RM, Sickles EA, Sollitto RA, et al. Clinical efficacy of mammographic screening in the elderly. Radiology 1995;194:193-7.
14. 14. Morimoto T, Sasa M, Yamaguchi T, et al. High detection rate of breast cancer by mass screening using mammography in Japan. Jpn J Cancer Res 1994;85:1193-5.
15. 15. Quiet CA, Ferguson DJ, Weichselbaum RR, et al. Natural history of node-negative breast cancer: A study of 826 patients with long-term follow-up. J Clin Oncol 1995;13:1144-51.
16. 16. Letton AH, Mason EM, Ramshaw BJ. Twenty-year review of a breast cancer screening project. Cancer 1996;77:104-6.
17. 17. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 1989;63: 181-7.
18. 18. Skinner DB. The incidence of cancer in Barrett's esophagus varies according to series. In: Giuli R, McCallum RW, eds. Benign lesions of the esophagus and cancer. New York: Springer-Verlag, 1989:764-5.
19. 19. Hameeteman W, Tytgat GNJ, Houthoff J, et al. Barrett's esophagus: Development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-56.
20. 20. Robertson CS, Mayberry JF, Nicholson DA, et al. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg 1988;75:760-3.
21. 21. Williamson WA, Ellis FH Jr, Gibb PS, et al. Barrett's esophagus: Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991; 151:2212-6.
22. 22. Van der Veen AH, Dees J, Blankensteijn JD, et al. Adenocarcinoma in Barrett's oesophagus: An overrated risk. Gut 1989;30:14-8.
23. 23. Spechler SJ, Robbins AH, Rubins HB, et al. Adenocarcinoma and Barrett's esophagus: An overrated risk? Gastroenterology 1984;87: 927-33.
24. 24. vander Burgh A, Dees J, Hop WCJ, et al. Oesophageal cancer is an uncommon cause of death in patients with Barrett's esophagus. Gut 1996;39:5-8.
25. 25. Provenzale D, Kemp JA, Arora S, et al. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 1994;89:670-80.
26. 26. Richter JE, Falk GW. Barrett's esophagus and adenocarcinoma: The need for a consensus conference. J Clin Gastroenterol 1996;23:88-90.
27. 27. Eisenberg JM. Clinical economics: A guide to the economic analysis of clinical practices. JAMA 1989;262:2879-86.
28. 28. Achkar E, Carey W. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. Am J Gastroenterol 1988;83:291-4.
29. 29. Provenzale D, Wong JB, Kemp JA, et al. Endoscopic surveillance for Barrett's esophagus; can we afford the cost? Am J Gastroenterol 1990;85:1224 (abstract).